Pfizer, Moderna COVID-19 vaccines will get label warning over rare heart risk, FDA says kdunleavy Thu, 06/24/2021 – 10:11 More: Pfizer, Moderna COVID-19 vaccines will get label warning over rare heart risk, FDA says Source: fierce
read moreGlaxoSmithKline plans to ‘relaunch’ Shingrix after the pandemic decimated sales esagonowsky Thu, 06/24/2021 – 10:08 More: GlaxoSmithKline plans to 'relaunch' Shingrix after the pandemic decimated sales Source: fierce
read more‘What’s next for patient advocacy?’ will take place on Tuesday 6th July at 8.30am More: ‘What’s next for patient advocacy?’ Senior leader speakers for Patient Partnership Index event announced Source: News
read moreCollaboration aims to accelerate Novartis’ use of data and digital technologies More: Novartis announces digital collaboration with Hewlett Packard Enterprise Source: News
read moreDesignation is based on data from a Phase IIb study including 856 patients with mild Alzheimer’s disease More: Lecanemab wins breakthrough therapy designation in Alzheimer’s disease Source: News
read morePreparations come on the heels of positive results from the Phase II ARC-7 study More: Arcus, Gilead prep Phase III studies of anti-TIGIT domvanalimab Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals